Chris Del Conte
Story Poster
7:14
Liucci joins TexAgs Radio to discuss 2024 conference slate, new QB commit
1 yr ago by Billy Liucci
The Southeastern Conference announced Texas A&M's 2024 slate which renews the beloved in-state rivalry between the Aggies and Longhorns. Our own executive editor Billy Liucci breaks down Texas A&M's schedule, the search for a recruiting director and more on TexAgs Radio.
Story Poster
20:06
The Loochador Podcast: Reacting to Texas A&M's 2024 opponents
1 yr ago by Billy Liucci
The Fightin' Texas Aggies learned their 2024 SEC opponents on Wednesday evening, and yes, they'll renew the rivalry with Texas AT Kyle Field that fall. Following the release show on the SEC Network, Billy Liucci and David Nuño share their thoughts on A&M's 2024 slate.
Story Poster
61:00
Billy Liucci joins TexAgs Radio on Tuesday morning (June 6)
1 yr ago by David Nuño
More Liucci on the radio was on Tuesday's menu. The TexAgs co-owner and executive editor joined in-studio for an extensive visit scattered across all three hours of the show to talk Aggie baseball, the 2022-2023 athletic calendar in Aggieland and football recruiting.
Story Poster
42:32
Lunch with Liucci: Billy Liucci joins TexAgs Radio (Friday, June 2)
1 yr ago by David Nuño
TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio Friday morning to share his thoughts on Texas A&M baseball's draw in the Stanford Regional, the vibe surrounding Aggie football and much more. Enjoy your lunch and catch up on what Billy said this morning.
Story Poster
Ask Liucci, Part 2: Thanksgiving traditions, Bayou Bengal predictions & more
3 yr ago by Billy Liucci
The day before Thanksgiving, Billy Liucci tackles another round of subscriber questions in this written edition of Ask Liucci. This week, Liucci discusses his holiday traditions, what he expects to see from the LSU Tigers this weekend and much more.
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.